TY - JOUR AU - Thuler, Luiz Claudio Santos AU - Bergmann, Anke AU - Casado, Letícia PY - 2012/09/28 Y2 - 2024/03/28 TI - Perfil das Pacientes com Câncer do Colo do Útero no Brasil, 2000-2009: Estudo de Base Secundária JF - Revista Brasileira de Cancerologia JA - Rev. Bras. Cancerol. VL - 58 IS - 3 SE - ARTIGO ORIGINAL DO - 10.32635/2176-9745.RBC.2012v58n3.583 UR - https://rbc.inca.gov.br/index.php/revista/article/view/583 SP - 351-357 AB - <p align="justify"><span style="font-family: AGaramondPro-Bold, serif;"><span style="font-size: small;"><strong>Introdução: </strong></span></span><span style="font-family: AGaramondPro-Regular, serif;"><span style="font-size: small;">O controle do c</span></span><span style="font-family: AGaramondPro-Regular, serif;"><span style="font-size: small;">â</span></span><span style="font-family: AGaramondPro-Regular, serif;"><span style="font-size: small;">ncer do colo do </span></span><span style="font-family: AGaramondPro-Regular, serif;"><span style="font-size: small;">útero</span></span><span style="font-family: AGaramondPro-Regular, serif;"><span style="font-size: small;"> foi definido como prioridade nas pol</span></span><span style="font-family: AGaramondPro-Regular, serif;"><span style="font-size: small;">í</span></span><span style="font-family: AGaramondPro-Regular, serif;"><span style="font-size: small;">ticas </span></span><span style="font-family: AGaramondPro-Regular, serif;"><span style="font-size: small;">públicas</span></span><span style="font-family: AGaramondPro-Regular, serif;"><span style="font-size: small;"> de sa</span></span><span style="font-family: AGaramondPro-Regular, serif;"><span style="font-size: small;">ú</span></span><span style="font-family: AGaramondPro-Regular, serif;"><span style="font-size: small;">de no Brasil, devido </span></span><span style="font-family: AGaramondPro-Regular, serif;"><span style="font-size: small;">à</span></span><span style="font-family: AGaramondPro-Regular, serif;"><span style="font-size: small;"> sua alta incid</span></span><span style="font-family: AGaramondPro-Regular, serif;"><span style="font-size: small;">ê</span></span><span style="font-family: AGaramondPro-Regular, serif;"><span style="font-size: small;">ncia, morbidade e mortalidade. </span></span><span style="font-family: AGaramondPro-Bold, serif;"><span style="font-size: small;"><strong>Objetivo: </strong></span></span><span style="font-family: AGaramondPro-Regular, serif;"><span style="font-size: small;">Descrever as </span></span><span style="font-family: AGaramondPro-Regular, serif;"><span style="font-size: small;">características</span></span> <span style="font-family: AGaramondPro-Regular, serif;"><span style="font-size: small;">demográficas</span></span><span style="font-family: AGaramondPro-Regular, serif;"><span style="font-size: small;"> e </span></span><span style="font-family: AGaramondPro-Regular, serif;"><span style="font-size: small;">clínicas</span></span><span style="font-family: AGaramondPro-Regular, serif;"><span style="font-size: small;"> da popula</span></span><span style="font-family: AGaramondPro-Regular, serif;"><span style="font-size: small;">çã</span></span><span style="font-family: AGaramondPro-Regular, serif;"><span style="font-size: small;">o com c</span></span><span style="font-family: AGaramondPro-Regular, serif;"><span style="font-size: small;">â</span></span><span style="font-family: AGaramondPro-Regular, serif;"><span style="font-size: small;">ncer do colo do </span></span><span style="font-family: AGaramondPro-Regular, serif;"><span style="font-size: small;">útero</span></span> <span style="font-family: AGaramondPro-Regular, serif;"><span style="font-size: small;">no país</span></span><span style="font-family: AGaramondPro-Regular, serif;"><span style="font-size: small;">, diagnosticada no per</span></span><span style="font-family: AGaramondPro-Regular, serif;"><span style="font-size: small;">í</span></span><span style="font-family: AGaramondPro-Regular, serif;"><span style="font-size: small;">odo de 2000 a 2009. </span></span><span style="font-family: AGaramondPro-Bold, serif;"><span style="font-size: small;"><strong>Método: </strong></span></span><span style="font-family: AGaramondPro-Regular, serif;"><span style="font-size: small;">Estudo observacional dos casos </span></span><span style="font-family: AGaramondPro-Regular, serif;"><span style="font-size: small;">analíticos</span></span><span style="font-family: AGaramondPro-Regular, serif;"><span style="font-size: small;"> de c</span></span><span style="font-family: AGaramondPro-Regular, serif;"><span style="font-size: small;">â</span></span><span style="font-family: AGaramondPro-Regular, serif;"><span style="font-size: small;">ncer do colo do </span></span><span style="font-family: AGaramondPro-Regular, serif;"><span style="font-size: small;">útero</span></span><span style="font-family: AGaramondPro-Regular, serif;"><span style="font-size: small;"> inseridos no M</span></span><span style="font-family: AGaramondPro-Regular, serif;"><span style="font-size: small;">ó</span></span><span style="font-family: AGaramondPro-Regular, serif;"><span style="font-size: small;">dulo Integrador dos Registros Hospitalares de C</span></span><span style="font-family: AGaramondPro-Regular, serif;"><span style="font-size: small;">â</span></span><span style="font-family: AGaramondPro-Regular, serif;"><span style="font-size: small;">ncer e no Registro Hospitalar de C</span></span><span style="font-family: AGaramondPro-Regular, serif;"><span style="font-size: small;">â</span></span><span style="font-family: AGaramondPro-Regular, serif;"><span style="font-size: small;">ncer do Estado de S</span></span><span style="font-family: AGaramondPro-Regular, serif;"><span style="font-size: small;">ã</span></span><span style="font-family: AGaramondPro-Regular, serif;"><span style="font-size: small;">o Paulo. Foi realizada an</span></span><span style="font-family: AGaramondPro-Regular, serif;"><span style="font-size: small;">á</span></span><span style="font-family: AGaramondPro-Regular, serif;"><span style="font-size: small;">lise descritiva das </span></span><span style="font-family: AGaramondPro-Regular, serif;"><span style="font-size: small;">variáveis.</span></span><span style="font-family: AGaramondPro-Regular, serif;"><span style="font-size: small;"> Este estudo foi aprovado pelo </span></span><span style="font-family: AGaramondPro-Regular, serif;"><span style="font-size: small;">Comitê</span></span><span style="font-family: AGaramondPro-Regular, serif;"><span style="font-size: small;"> de </span></span><span style="font-family: AGaramondPro-Regular, serif;"><span style="font-size: small;">Ética</span></span><span style="font-family: AGaramondPro-Regular, serif;"><span style="font-size: small;"> em Pesquisa do INCA sob o </span></span><span style="font-family: AGaramondPro-Regular, serif;"><span style="font-size: small;">número</span></span><span style="font-family: AGaramondPro-Regular, serif;"><span style="font-size: small;"> 128/11. </span></span><span style="font-family: AGaramondPro-Bold, serif;"><span style="font-size: small;"><strong>Resultados: </strong></span></span><span style="font-family: AGaramondPro-Regular, serif;"><span style="font-size: small;">Foram inclu</span></span><span style="font-family: AGaramondPro-Regular, serif;"><span style="font-size: small;">í</span></span><span style="font-family: AGaramondPro-Regular, serif;"><span style="font-size: small;">dos 77.317 casos. O </span></span><span style="font-family: AGaramondPro-Regular, serif;"><span style="font-size: small;">número</span></span><span style="font-family: AGaramondPro-Regular, serif;"><span style="font-size: small;"> de casos e a </span></span><span style="font-family: AGaramondPro-Regular, serif;"><span style="font-size: small;">distribuição</span></span><span style="font-family: AGaramondPro-Regular, serif;"><span style="font-size: small;"> proporcional dos estadiamentos foram semelhantes nos dois quinqu</span></span><span style="font-family: AGaramondPro-Regular, serif;"><span style="font-size: small;">ê</span></span><span style="font-family: AGaramondPro-Regular, serif;"><span style="font-size: small;">nios analisados (2000-2004 </span></span><span style="font-family: AGaramondPro-Italic, serif;"><span style="font-size: small;"><em>versus </em></span></span><span style="font-family: AGaramondPro-Regular, serif;"><span style="font-size: small;">2005-2009). A m</span></span><span style="font-family: AGaramondPro-Regular, serif;"><span style="font-size: small;">é</span></span><span style="font-family: AGaramondPro-Regular, serif;"><span style="font-size: small;">dia de idade ao diagn</span></span><span style="font-family: AGaramondPro-Regular, serif;"><span style="font-size: small;">ó</span></span><span style="font-family: AGaramondPro-Regular, serif;"><span style="font-size: small;">stico foi de 49,2 anos (55,3% tinham menos de 50 anos), com predom</span></span><span style="font-family: AGaramondPro-Regular, serif;"><span style="font-size: small;">í</span></span><span style="font-family: AGaramondPro-Regular, serif;"><span style="font-size: small;">nio de mulheres de cor parda (47,9%), com ensino fundamental incompleto (49,0%) e casadas (51,5%). O estadiamento III foi o mais frequente (29,0%) e na maioria dos casos o tipo </span></span><span style="font-family: AGaramondPro-Regular, serif;"><span style="font-size: small;">histológico</span></span><span style="font-family: AGaramondPro-Regular, serif;"><span style="font-size: small;"> foi carcinoma (91,3%). Ao final do primeiro tratamento, 48,9% encontravam-se sem evid</span></span><span style="font-family: AGaramondPro-Regular, serif;"><span style="font-size: small;">ê</span></span><span style="font-family: AGaramondPro-Regular, serif;"><span style="font-size: small;">ncia de doen</span></span><span style="font-family: AGaramondPro-Regular, serif;"><span style="font-size: small;">ç</span></span><span style="font-family: AGaramondPro-Regular, serif;"><span style="font-size: small;">a ou em </span></span><span style="font-family: AGaramondPro-Regular, serif;"><span style="font-size: small;">remissão</span></span><span style="font-family: AGaramondPro-Regular, serif;"><span style="font-size: small;"> completa. </span></span><span style="font-family: AGaramondPro-Bold, serif;"><span style="font-size: small;"><strong>Conclusão: </strong></span></span><span style="font-family: AGaramondPro-Regular, serif;"><span style="font-size: small;">No Brasil, mulheres com diagn</span></span><span style="font-family: AGaramondPro-Regular, serif;"><span style="font-size: small;">ó</span></span><span style="font-family: AGaramondPro-Regular, serif;"><span style="font-size: small;">stico de c</span></span><span style="font-family: AGaramondPro-Regular, serif;"><span style="font-size: small;">â</span></span><span style="font-family: AGaramondPro-Regular, serif;"><span style="font-size: small;">ncer do colo do </span></span><span style="font-family: AGaramondPro-Regular, serif;"><span style="font-size: small;">útero</span></span><span style="font-family: AGaramondPro-Regular, serif;"><span style="font-size: small;"> diagnosticadas entre 2000 e 2009 eram em sua maioria jovens, de cor parda, com baixa escolaridade, casadas, apresentaram estadiamento </span></span><span style="font-family: AGaramondPro-Regular, serif;"><span style="font-size: small;">avançado</span></span><span style="font-family: AGaramondPro-Regular, serif;"><span style="font-size: small;"> ao diagn</span></span><span style="font-family: AGaramondPro-Regular, serif;"><span style="font-size: small;">ó</span></span><span style="font-family: AGaramondPro-Regular, serif;"><span style="font-size: small;">stico e evolu</span></span><span style="font-family: AGaramondPro-Regular, serif;"><span style="font-size: small;">í</span></span><span style="font-family: AGaramondPro-Regular, serif;"><span style="font-size: small;">ram sem evid</span></span><span style="font-family: AGaramondPro-Regular, serif;"><span style="font-size: small;">ê</span></span><span style="font-family: AGaramondPro-Regular, serif;"><span style="font-size: small;">ncia de doen</span></span><span style="font-family: AGaramondPro-Regular, serif;"><span style="font-size: small;">ç</span></span><span style="font-family: AGaramondPro-Regular, serif;"><span style="font-size: small;">a ou para </span></span><span style="font-family: AGaramondPro-Regular, serif;"><span style="font-size: small;">remissão</span></span><span style="font-family: AGaramondPro-Regular, serif;"><span style="font-size: small;"> completa ao final do primeiro tratamento.</span></span></p> ER -